𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6-Month Double-Blind Placebo-Controlled Trial

✍ Scribed by Chad Deal; Molly Omizo; Elliott N Schwartz; Erik F Eriksen; Per Cantor; Jingyuan Wang; Emmett V Glass; Stephen L Myers; John H Krege

Book ID
111485327
Publisher
American Society for Bone and Mineral Research
Year
2005
Tongue
English
Weight
111 KB
Volume
20
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of teriparatide versus alendrona
Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six–month results of a randomized, double-blind, controlled trial
✍ Kenneth G. Saag; Jose R. Zanchetta; Jean-Pierre Devogelaer; Robert A. Adler; Ric πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

## Abstract ## Objective To compare the bone anabolic drug teriparatide (20 ΞΌg/day) with the antiresorptive drug alendronate (10 mg/day) for treating glucocorticoid‐induced osteoporosis (OP). ## Methods This was a 36‐month, randomized, double‐blind, controlled trial in 428 subjects with OP (ages